A Study of WX390 in Patients With Advanced Solid Tumors
Clinical trial NCT06117540 · RECRUITING
Trial details
- NCT number
- NCT06117540
- Sponsor
- Shanghai Jiatan Pharmatech Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-11
- Primary completion
- 2025-06-12
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.